Pleural "drop metastases" 21 years after resection of a thymoma

Chia Chun Chiang, Angela M. Parsons, J. Scott Kriegshauser, Harshita Paripati, Matthew A. Zarka, A. Arturo Leis

Research output: Contribution to journalArticle

Abstract

Introduction: We describe an unusual case of pleural drop metastases 21 years after complete resection of an encapsulated thymoma in a Southeast Asian patient with myasthenia gravis (MG). Methods: This investigation includes a case report and brief review of the literature. Results: The patient presented in 2015 with generalized weakness, fatigue, and shortness of breath, but no diplopia, ptosis, dysphagia, or dysarthria. Because these symptoms were atypical for an MG exacerbation, a de-novo work-up was performed. Chest computed tomography (CT) showed numerous pleural nodules ("drop metastases"), and CT-guided biopsy revealed metastatic thymoma. Conclusions: The average disease-free interval for thymoma ranges from 68 to 86 months. Pleural and mediastinal recurrence are more common than distant hematogenous recurrence. Adverse prognostic factors include an initial higher Masaoka stage, incomplete resection, older age, and pleural or pericardial involvement. Despite apparent complete resection of thymoma, clinicians should remain vigilant for recurrence for as long as 20 years after initial management. Long-term follow-up with radiologic surveillance is recommended.

Original languageEnglish (US)
JournalMuscle and Nerve
DOIs
StateAccepted/In press - 2017

Fingerprint

Thymoma
Neoplasm Metastasis
Myasthenia Gravis
Recurrence
Tomography
Dysarthria
Diplopia
Deglutition Disorders
Dyspnea
Fatigue
Thorax
Biopsy

Keywords

  • Disease surveillance
  • Disease-free survival
  • Drop metastases
  • Myasthenia gravis
  • Recurrence
  • Thymoma

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)

Cite this

Chiang, C. C., Parsons, A. M., Kriegshauser, J. S., Paripati, H., Zarka, M. A., & Leis, A. A. (Accepted/In press). Pleural "drop metastases" 21 years after resection of a thymoma. Muscle and Nerve. https://doi.org/10.1002/mus.25479

Pleural "drop metastases" 21 years after resection of a thymoma. / Chiang, Chia Chun; Parsons, Angela M.; Kriegshauser, J. Scott; Paripati, Harshita; Zarka, Matthew A.; Leis, A. Arturo.

In: Muscle and Nerve, 2017.

Research output: Contribution to journalArticle

Chiang, Chia Chun ; Parsons, Angela M. ; Kriegshauser, J. Scott ; Paripati, Harshita ; Zarka, Matthew A. ; Leis, A. Arturo. / Pleural "drop metastases" 21 years after resection of a thymoma. In: Muscle and Nerve. 2017.
@article{74c1bbe31a354554a26666f4f977bc2a,
title = "Pleural {"}drop metastases{"} 21 years after resection of a thymoma",
abstract = "Introduction: We describe an unusual case of pleural drop metastases 21 years after complete resection of an encapsulated thymoma in a Southeast Asian patient with myasthenia gravis (MG). Methods: This investigation includes a case report and brief review of the literature. Results: The patient presented in 2015 with generalized weakness, fatigue, and shortness of breath, but no diplopia, ptosis, dysphagia, or dysarthria. Because these symptoms were atypical for an MG exacerbation, a de-novo work-up was performed. Chest computed tomography (CT) showed numerous pleural nodules ({"}drop metastases{"}), and CT-guided biopsy revealed metastatic thymoma. Conclusions: The average disease-free interval for thymoma ranges from 68 to 86 months. Pleural and mediastinal recurrence are more common than distant hematogenous recurrence. Adverse prognostic factors include an initial higher Masaoka stage, incomplete resection, older age, and pleural or pericardial involvement. Despite apparent complete resection of thymoma, clinicians should remain vigilant for recurrence for as long as 20 years after initial management. Long-term follow-up with radiologic surveillance is recommended.",
keywords = "Disease surveillance, Disease-free survival, Drop metastases, Myasthenia gravis, Recurrence, Thymoma",
author = "Chiang, {Chia Chun} and Parsons, {Angela M.} and Kriegshauser, {J. Scott} and Harshita Paripati and Zarka, {Matthew A.} and Leis, {A. Arturo}",
year = "2017",
doi = "10.1002/mus.25479",
language = "English (US)",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Pleural "drop metastases" 21 years after resection of a thymoma

AU - Chiang, Chia Chun

AU - Parsons, Angela M.

AU - Kriegshauser, J. Scott

AU - Paripati, Harshita

AU - Zarka, Matthew A.

AU - Leis, A. Arturo

PY - 2017

Y1 - 2017

N2 - Introduction: We describe an unusual case of pleural drop metastases 21 years after complete resection of an encapsulated thymoma in a Southeast Asian patient with myasthenia gravis (MG). Methods: This investigation includes a case report and brief review of the literature. Results: The patient presented in 2015 with generalized weakness, fatigue, and shortness of breath, but no diplopia, ptosis, dysphagia, or dysarthria. Because these symptoms were atypical for an MG exacerbation, a de-novo work-up was performed. Chest computed tomography (CT) showed numerous pleural nodules ("drop metastases"), and CT-guided biopsy revealed metastatic thymoma. Conclusions: The average disease-free interval for thymoma ranges from 68 to 86 months. Pleural and mediastinal recurrence are more common than distant hematogenous recurrence. Adverse prognostic factors include an initial higher Masaoka stage, incomplete resection, older age, and pleural or pericardial involvement. Despite apparent complete resection of thymoma, clinicians should remain vigilant for recurrence for as long as 20 years after initial management. Long-term follow-up with radiologic surveillance is recommended.

AB - Introduction: We describe an unusual case of pleural drop metastases 21 years after complete resection of an encapsulated thymoma in a Southeast Asian patient with myasthenia gravis (MG). Methods: This investigation includes a case report and brief review of the literature. Results: The patient presented in 2015 with generalized weakness, fatigue, and shortness of breath, but no diplopia, ptosis, dysphagia, or dysarthria. Because these symptoms were atypical for an MG exacerbation, a de-novo work-up was performed. Chest computed tomography (CT) showed numerous pleural nodules ("drop metastases"), and CT-guided biopsy revealed metastatic thymoma. Conclusions: The average disease-free interval for thymoma ranges from 68 to 86 months. Pleural and mediastinal recurrence are more common than distant hematogenous recurrence. Adverse prognostic factors include an initial higher Masaoka stage, incomplete resection, older age, and pleural or pericardial involvement. Despite apparent complete resection of thymoma, clinicians should remain vigilant for recurrence for as long as 20 years after initial management. Long-term follow-up with radiologic surveillance is recommended.

KW - Disease surveillance

KW - Disease-free survival

KW - Drop metastases

KW - Myasthenia gravis

KW - Recurrence

KW - Thymoma

UR - http://www.scopus.com/inward/record.url?scp=85007574699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007574699&partnerID=8YFLogxK

U2 - 10.1002/mus.25479

DO - 10.1002/mus.25479

M3 - Article

C2 - 27862032

AN - SCOPUS:85007574699

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

ER -